Effect of Puerarin on Heart Health in Men

• Status: Completed
• Trial end date: 2021-04-17
• Target enrollment: 0
• Participant gender: Male

Summary

This study aims to assess the effect of puerarin supplementation on cardiovascular disease risk factors in men.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The University of Hong Kong
• Collaborators: Health and Medical Research Fund; Health and Medical Research Fund, Hong Kong
• Treatments: Puerarin

Criteria

Inclusion Criteria:

• Men

• Aged 18 to 50 years

• Chinese ethnicity

• Willing to make return visits

• Not currently taking any traditional Chinese medicine (including puerarin) supplementation

• Not currently receiving hormone replacement therapy, such as testosterone replacement therapy, in the past 12 months

• Free of any congenital diseases

• Free of any infectious diseases e.g. seasonal influenza

• With no history of any chronic diseases including coronary heart disease (ischemic heart disease), myocardial infarction (heart attack), stroke, diabetes and cancer

• Have a 10-year risk of ischemic heart disease of less than 10%

Exclusion Criteria:

• Women

• Men, who did not meet the aforementioned inclusion criteria, and/or unable or unwilling to provide consent